Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) shares reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as GBX 57.40 and last traded at GBX 55.90, with a volume of 18381 shares traded. The stock had previously closed at GBX 56.
Beximco Pharmaceuticals Trading Down 0.2%
The firm has a market capitalization of £249.38 million, a PE ratio of 0.03 and a beta of 0.25. The firm has a fifty day moving average of GBX 49.55 and a 200 day moving average of GBX 44.98. The company has a debt-to-equity ratio of 5.27, a quick ratio of 0.37 and a current ratio of 4.13.
Beximco Pharmaceuticals Company Profile
Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands. Since its inception, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines.
Read More
- Five stocks we like better than Beximco Pharmaceuticals
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
- Why Lowe’s Could Be a Bargain Before Housing Recovers
- Okta’s AI Tailwind Could Put This Forgotten Software Stock Back in Play
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
